A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Public ClinicalTrials.gov record NCT06807281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Long-Term, Open Label Study Evaluating the Safety and Efficacy of Abrocitinib, With or Without Topical Medications Administered to Pediatric Participants Aged 2 Years and Older With Moderate-to-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in children 2 years of age or older with moderate-to-severe atopic dermatitis. The study will enroll two groups: participants who have completed other abrocitinib studies and participants who have never participated in abrocitinib studies.
Study identification
- NCT ID
- NCT06807281
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 2 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2, 2025 (Actual)
- Primary completion
- Feb 22, 2032 (Estimated)
- Completion
- Feb 22, 2032 (Estimated)
- Last update posted
- Oct 13, 2026
2025 – 2032
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Dermatology & Skin Health Center | Birmingham | Alabama | 35244 | Recruiting |
| Arkansas Research Trials | North Little Rock | Arkansas | 72117 | Recruiting |
| Investigational Drug Service - Rady Childrens Hospital-San Diego | San Diego | California | 92123 | Not yet recruiting |
| University of California, San Diego/ Rady Children's Hospital - San Diego | San Diego | California | 92123 | Not yet recruiting |
| Solutions Through Advanced Research | Jacksonville | Florida | 32256 | Recruiting |
| Ada West Research - Meridian | Meridian | Idaho | 83646 | Not yet recruiting |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | Recruiting |
| Saint Louis University | St Louis | Missouri | 63104 | Recruiting |
| Medical University of South Carolina - South Carolina Translational Research Nexus Clinic | Charleston | South Carolina | 29425 | Recruiting |
| Tribe Clinical Research, LLC | Greenville | South Carolina | 29607 | Recruiting |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78235 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06807281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2026 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06807281 live on ClinicalTrials.gov.